Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | monoglyceride lipase | Starlite/ChEMBL | References |
Rattus norvegicus | Anandamide amidohydrolase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus multilocularis | fatty acid amide hydrolase 1 | Anandamide amidohydrolase | 579 aa | 470 aa | 28.3 % |
Plasmodium falciparum | esterase, putative | monoglyceride lipase | 303 aa | 254 aa | 19.7 % |
Onchocerca volvulus | Anandamide amidohydrolase | 579 aa | 539 aa | 34.7 % | |
Echinococcus granulosus | fatty acid amide hydrolase 1 | Anandamide amidohydrolase | 579 aa | 470 aa | 28.7 % |
Schistosoma japonicum | Fatty-acid amide hydrolase 1, putative | Anandamide amidohydrolase | 579 aa | 499 aa | 24.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0084 | 0.4683 | 0.5 |
Leishmania major | monoglyceride lipase, putative | 0.0084 | 0.4683 | 0.5 |
Onchocerca volvulus | 0.005 | 0 | 0.5 | |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0084 | 0.4683 | 0.5 |
Schistosoma mansoni | fatty-acid amide hydrolase | 0.0123 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0084 | 0.4683 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0084 | 0.4683 | 0.5 |
Onchocerca volvulus | 0.005 | 0 | 0.5 | |
Onchocerca volvulus | 0.005 | 0 | 0.5 | |
Plasmodium falciparum | lysophospholipase, putative | 0.0084 | 0.4683 | 0.5 |
Onchocerca volvulus | 0.005 | 0 | 0.5 | |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0084 | 0.4683 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0123 | 1 | 1 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0084 | 0.4683 | 0.5 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0123 | 1 | 1 |
Onchocerca volvulus | 0.005 | 0 | 0.5 | |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0084 | 0.4683 | 0.5 |
Plasmodium vivax | PST-A protein | 0.0084 | 0.4683 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0084 | 0.4683 | 0.5 |
Onchocerca volvulus | 0.005 | 0 | 0.5 | |
Onchocerca volvulus | 0.005 | 0 | 0.5 | |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0123 | 1 | 1 |
Onchocerca volvulus | 0.005 | 0 | 0.5 | |
Onchocerca volvulus | 0.005 | 0 | 0.5 | |
Onchocerca volvulus | 0.005 | 0 | 0.5 | |
Mycobacterium ulcerans | lysophospholipase | 0.0084 | 0.4683 | 0.5 |
Onchocerca volvulus | 0.005 | 0 | 0.5 | |
Onchocerca volvulus | 0.005 | 0 | 0.5 | |
Plasmodium falciparum | lysophospholipase, putative | 0.0084 | 0.4683 | 0.5 |
Schistosoma mansoni | amidase | 0.0123 | 1 | 1 |
Onchocerca volvulus | 0.005 | 0 | 0.5 | |
Onchocerca volvulus | Dopamine\/Ecdysteroid receptor homolog | 0.005 | 0 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.0084 | 0.4683 | 0.5 |
Onchocerca volvulus | 0.005 | 0 | 0.5 | |
Onchocerca volvulus | Neuropeptide F receptor homolog | 0.005 | 0 | 0.5 |
Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.0084 | 0.4683 | 0.5 |
Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.0084 | 0.4683 | 0.5 |
Plasmodium falciparum | esterase, putative | 0.0084 | 0.4683 | 0.5 |
Mycobacterium tuberculosis | Possible lysophospholipase | 0.0084 | 0.4683 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0084 | 0.4683 | 0.5 |
Onchocerca volvulus | 0.005 | 0 | 0.5 | |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0084 | 0.4683 | 0.5 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0123 | 1 | 1 |
Onchocerca volvulus | 0.005 | 0 | 0.5 | |
Trypanosoma cruzi | monoglyceride lipase, putative | 0.0084 | 0.4683 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0084 | 0.4683 | 0.5 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0123 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0084 | 0.4683 | 0.5 |
Onchocerca volvulus | 0.005 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 48.7 uM | Agonist activity at rat TRPA1 receptor expressed in HEK293 cells assessed as increase in intracellular Ca2+ concentration by spectrofluorimetric analysis | ChEMBL. | 23474898 |
Efficacy (binding) | < 10 % | Agonist activity at human TRPV1 receptor expressed in HEK293 cells assessed as increase in intracellular Ca2+ concentration by spectrofluorimetric analysis relative to ionomycin | ChEMBL. | 23474898 |
Efficacy (binding) | = 348.8 % | Agonist activity at rat TRPA1 receptor expressed in HEK293 cells assessed as increase in intracellular Ca2+ concentration by spectrofluorimetric analysis relative to allyl isothiocyanate | ChEMBL. | 23474898 |
IC50 (binding) | = 35.5 nM | Inhibition of FAAH in rat brain membranes assessed as [14C]AEA hydrolysis to [14C]Ethanolamine after 30 mins by scintillation counting analysis | ChEMBL. | 23474898 |
IC50 (binding) | > 1000 nM | Inhibition of MAGL (unknown origin) expressed in African green monkey COS7 cell cytosolic fraction assessed as [3H]2-AG hydrolysis to [3H]arachidonic acid after 20 mins by beta counting analysis | ChEMBL. | 23474898 |
IC50 (binding) | = 45.2 uM | Antagonist activity at rat TRPA1 receptor expressed in HEK293 cells assessed as inhibition of allyl isothiocyanate-induced intracellular Ca2+ elevation incubated for 5 mins prior to allyl isothiocyanate-stimulation by spectrofluorimetric analysis | ChEMBL. | 23474898 |
IC50 (binding) | > 100 uM | Antagonist activity at human TRPV1 receptor expressed in HEK293 cells assessed as inhibition of capsaicin-induced intracellular Ca2+ elevation incubated for 5 mins prior to capsaicin-stimulation by spectrofluorimetric analysis | ChEMBL. | 23474898 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.